Dynamic Changes in the Immunological Characteristics of T Lymphocytes in Surviving Patients with Severe Fever with Thrombocytopenia Syndrome (SFTS)
Overview
Authors
Affiliations
Objective: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality. T cell deficiency has recently been described, but the changes in T cell functionality during acute SFTS virus (SFTSV) infection and the mechanisms leading to T lymphocyte death remain largely unknown. This study was conducted to evaluate T cell functionality and the expression of apoptotic/proliferation and activation/inhibition markers during acute SFTSV infection.
Methods: Twenty-eight surviving SFTS patients were sequentially sampled during their entire hospital stay. SFTSV RNA copies were investigated using real-time RT-PCR. The expression levels of apoptotic markers (annexin V and CD95) and proliferation and activation markers (Ki-67, HLA-DR, and CD25) and the expression levels of programmed cell death-1 (PD-1), interferon gamma (IFN-γ), and granzyme B in T cells were evaluated by flow cytometry for the SFTS patients.
Results: In parallel with T cell depletion, higher annexin V and CD95 expression was observed in SFTS patients. Additionally, the expression levels of Ki-67, HLA-DR, CD25, and PD-1 and the levels of IFN-γ and granzyme B in T lymphocytes were markedly increased in the SFTS patients.
Conclusions: T cell proliferation, activation, and functional enhancement were apparent despite the observation of T cell apoptosis, suggesting that these processes are involved in the complex protective response to SFTSV infection.
Xu N, Wen S, Yao Y, Guan Y, Zhao L, Yang L J Clin Microbiol. 2024; 63(1):e0128224.
PMID: 39688402 PMC: 11784442. DOI: 10.1128/jcm.01282-24.
Zhang Y, Sun Q, Liu T, Chang C, Chen X, Duan Q J Inflamm Res. 2024; 17:8357-8374.
PMID: 39530000 PMC: 11552436. DOI: 10.2147/JIR.S485118.
Wang G, Liu P, Xie H, Niu C, Lyu J, An Y J Inflamm Res. 2024; 17:7627-7637.
PMID: 39479263 PMC: 11521778. DOI: 10.2147/JIR.S478520.
Li M, Hu S, Xu L, Gao J, Zheng X, Li X Heliyon. 2024; 10(16):e35950.
PMID: 39224371 PMC: 11367551. DOI: 10.1016/j.heliyon.2024.e35950.
Niu Y, Liu Y, Huang L, Liu W, Cheng Q, Liu T Front Immunol. 2024; 15:1348836.
PMID: 38646523 PMC: 11026560. DOI: 10.3389/fimmu.2024.1348836.